CTT: Marktkapitalisierung 12 Mio. / Einnahmen demnächst 20 Mio. bis 50 Mio. jährlich ?

Man beachte die geringe Marktkapitalisierung dieser Gesellschaft von derzeit nur 12 Mio. $ !

Erwartet werden revenues von 25 Mio. bis 50 Mio. jährlich in/ab den Jahren 2009 bzw. 2010 ff.

In diesen news hat am 24.02.2009 CTT seit langem wieder ein Mal auf sich aufmerksam gemacht:

Fairfield, CT - (February 24, 2009) - Competitive Technologies, Inc. (NYSE Alternext US: CTT) announced today that it has signed an agreement with Life Epistéme srl granting them exclusive distribution rights in each of 29 countries throughout Europe, Asia, Africa, the Middle East, South America and Oceania for CTT's pain management medical device. The device is a non-invasive method for rapid treatment of high-intensity oncologic and neuropathic pain, including pain resistant to morphine and other drugs.
"We have seen this innovative device successfully used in Italy, and are proud to be able to bring it to other patients around the world," said Dr. Domenico Pecorini, one of the founders of Life Epistéme. "The population in the countries included in our contract totals over 1.7 billion people, about 25% of the world's population. Our network of distributors in strategic centers around the world will facilitate the delivery process for the device."
"Life Epistéme provides CTT with a strong and effective global partner," said John B. Nano, CTT's Chairman, President and CEO. "This represents a remarkable opportunity for our innovative pain management medical device. Our exclusive signed distribution agreements for this device now cover over 45% of the world's population and the contractual minimums have a retail sales value of over $25 million for 2009 and about $50 million for 2010. CTT will share in revenue derived from sales of the device to our distributors and both CTT and our distributors expect sales to exceed the contract minimums."

http://www.competitivetech.net/


><